Herbalife Nutrition Ltd.
Herbalife Nutrition Ltd. (HLF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Herbalife Nutrition Ltd. (HLF), featuring income statements, balance sheets, and cash flow data.
Herbalife Nutrition Ltd. (HLF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Herbalife Nutrition Ltd. HLF financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.22B | $1.21B | $1.24B | $1.28B |
Cost of Revenue | $265.20M | $267.50M | $268.70M | $317.20M |
Gross Profit | $956.50M | $939.90M | $971.60M | $963.90M |
Gross Profit Ratio | $0.78 | $0.78 | $0.78 | $0.75 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $431.90M | $436.90M | $444.00M | $870.70M |
Operating Expenses | $833.70M | $856.90M | $807.30M | $870.70M |
Total Costs & Expenses | $1.10B | $1.10B | $1.11B | $1.19B |
Interest Income | $2.60M | $3.00M | $2.90M | $2.70M |
Interest Expense | $54.60M | $56.90M | $59.40M | $60.40M |
Depreciation & Amortization | $30.70M | $29.00M | $30.60M | $32.60M |
EBITDA | $156.10M | $138.50M | $160.60M | $105.20M |
EBITDA Ratio | $0.13 | $0.11 | $0.13 | $0.08 |
Operating Income | $122.80M | $106.50M | $127.10M | $93.20M |
Operating Income Ratio | $0.10 | $0.09 | $0.10 | $0.07 |
Other Income/Expenses (Net) | -$52.00M | -$53.90M | -$56.50M | -$68.20M |
Income Before Tax | $70.80M | $52.60M | $70.60M | $12.20M |
Income Before Tax Ratio | $0.06 | $0.04 | $0.06 | $0.010 |
Income Tax Expense | $20.40M | -$125.30M | $23.20M | $7.50M |
Net Income | $50.40M | $177.90M | $47.40M | $4.70M |
Net Income Ratio | $0.04 | $0.15 | $0.04 | $0.004 |
EPS | $0.50 | $1.76 | $0.47 | $0.05 |
Diluted EPS | $0.49 | $1.74 | $0.47 | $0.05 |
Weighted Avg Shares Outstanding | $101.50M | $101.10M | $100.90M | $100.60M |
Weighted Avg Shares Outstanding (Diluted) | $102.20M | $102.00M | $101.90M | $101.70M |
Over the past four quarters, Herbalife Nutrition Ltd. demonstrated steady revenue growth, increasing from $1.28B in Q2 2024 to $1.22B in Q1 2025. Operating income reached $122.80M in Q1 2025, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $156.10M, reflecting operational efficiency. Net income dropped to $50.40M, with EPS at $0.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan